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Ireland
The Health Research Board (HRB) Alcohol Overview 
was published in April 2021, the fourth in a series 
that provides updates on alcohol consumption, 
its related harms, and policy responses in Ireland.1 
Using the HRB National Drugs Library, the overview 
is compiled using a variety of Irish data sources, 
published Irish literature, and existing information 
systems and surveys.
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In brief
Substance use in young people (aged 10–24 
years) is a significant health and social problem 
throughout the world. The 2013 Global Burden 
of Disease estimated that substance use 
among young men was responsible for 14% 
of total health burden. Recent findings have 
underlined the neurobiological vulnerability of 
young adults and the impact of co-occurring 
substance use disorders and mental health 
problems that emerge in adolescence. 
Adolescence is the peak period for initiation 
of substance use. A consistent finding from 
the international literature is that levels 
and frequency of use of drugs, alcohol, and 
tobacco begin to increase in mid-adolescence 
and peak in very early adulthood. These 
are key periods of change, cognitive and 
emotional development, and transitioning 
into employment, stable relationships, and 
parenthood.
Preventing, delaying or reducing young people’s 
use of alcohol and other drugs is a major part 
of all governments’ drug strategies. Unlike other 
interventions, which might be resisted for moral 
or ideological reasons, prevention programmes 
are widely supported by the general public. Yet, 
unlike evidence-based harm reduction policies 
that often face sustained opposition, many of 
the most common prevention programmes are 
supported by a very narrow evidence base. This 
is because most prevention options in place 
have not been evaluated. Those that have been 
evaluated are largely concentrated in school 
settings that facilitate research opportunities and 
the possibility to collect follow-up information 
on the participants in these programmes. It is an 
enormously difficult task to influence behaviour 
at the time of life when people go through rapid 
changes in neurobehavioural and psychosocial 
functioning. Entering early adulthood is a 
complex, challenging, and often bewildering 
experience for young people. Establishing a 
scientific approach to enable young people to 
navigate the many risks they face is probably the 
most difficult, and most important, task faced 
by decision-makers working on substance use 
policies.
This issue of Drugnet Ireland highlights some 
recent interesting developments in prevention 
studies. There is a strong correlation between 
diagnosed psychiatric disorder and substance 
use. Attention deficit hyperactivity disorder 
(ADHD), conduct, and personality disorder as 
well as affective disorders have been linked 
to increased substance use in adolescence. 
A systematic review published in 2020 finds 
that school-based programmes applying 
interventions based on positive psychology 
interventions can have positive effects on 
psychological wellbeing, and their inclusion in the 
school curriculum should be explored. Bullying is 
an important risk factor for poor mental health 
outcomes, and two 2020 reviews have found a 
small but significant effect from evaluations of 
anti-bullying interventions.
Prevention science has made great progress. 
Despite this, and the increasing availability 
of high-quality evidence in the field, it can 
be difficult for stakeholders to decide on the 
best approach. Selecting and implementing 
prevention interventions is a major undertaking 
and decisions can be difficult to reverse if new 
evidence emerges challenging the efficacy of 
programmes already in place. Initiatives like the 
Xchange Registry, described in an article in this 
issue, provide the type of valuable scientific and 
experiential information to support informed 
decision-making and more effective responses 









   











1 Alcohol overview   continued
Introduction
Alcohol use is the seventh leading risk factor for 
both deaths and disability-adjusted life years 
globally, despite the fact that one-half of the 
world’s population does not drink. Ireland ranks 
ninth highest per capita alcohol consumption 
of all OECD (Organisation for Economic Co-
operation and Development) member countries.2
Alcohol consumption
Since 2013, alcohol consumption levels in Ireland 
have remained stable but high: 19% higher than 
the stated aim of the Irish Government to reduce 
per capita alcohol consumption in Ireland to 
9.1 litres by 2020. In 2019, per capita alcohol 
consumption per adult aged 15 and over was 10.8 
litres of pure alcohol (see Figure 1).3,4,5 However, 
considering that one-quarter of the population 
do not drink alcohol at all, the number of litres 
consumed per person is even greater.
Consumption patterns
Patterns of alcohol consumption as well as 
high-volume drinking increases the risk of 
alcohol-related harm. Healthy Ireland Survey 
data showed that more than one-half (52%) of 
all drinkers were classified as hazardous drinkers 
using the World Health Organization’s AUDIT-C 
screening tool.6 This screening tool takes 
account of frequency and volume of drinking as 
well as heavy episodic drinking (HED), defined 
as consuming six standard drinks or more on a 
single drinking occasion. Hazardous drinking was 
more common among men (70%) than women 
(34%), particularly younger men, with almost four 
in five (78%) of 25–34-year-old males meeting 
the criteria for hazardous drinking.7
Despite the level of hazardous drinking 
patterns among Irish drinkers, the majority 
of drinkers considered themselves as being a 
light or moderate drinker (74%), indicating an 
unawareness of what constitutes binge drinking 
and that their patterns of drinking may be 
considered hazardous.
Figure 1: How much are we drinking?
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Alcohol consumption among young people
Data from the Irish Health Behaviour in School-
aged Children (HBSC) 2018 study indicate that 
82% of schoolchildren have consumed their 
first alcoholic drink by the age of 17 years and 
for all ages, with the exception of 15-year-olds, 
getting alcohol from parents and guardians was 
the most common way children obtained alcohol 
(see Figure 2).8 Lifetime drunkenness ranged 
from 5% of 13-year-olds to 62% of 17-year-
olds. Trends in alcohol consumption since 1998 
show a continuous decline in the percentage 
of schoolchildren who drink alcohol, especially 
among 13–15-year-olds. This is encouraging, 
as this group is particularly vulnerable to 
experiencing alcohol-related harm. The same 
trend has not been observed among 17-year-
olds, where there has been little change in 
alcohol use and drunkenness since 1998.
Alcohol consumption among parents
More than one-quarter of parents (28%) engaged 
in HED at least once a month, while 5% were 
classified as dependent on alcohol.6
Alcohol overview   continued Alcohol-related harm in Ireland
The Hospital In-Patient Enquiry (HIPE) scheme 
collects clinical and administrative data on 
discharges (including deaths) from acute Irish 
hospitals. For the overview, all alcohol-related 
discharges that were either wholly attributable 
to alcohol (alcohol is a necessary cause for these 
conditions to manifest) or partially attributable 
(conditions where alcohol may be one of a range 
of causative factors) were analysed (see Figure 3).
Wholly attributable alcohol-related 
discharges
In 2018, acute conditions such as alcohol 
poisoning and intoxication accounted for 12% of 
wholly attributable alcohol-related discharges. 
Chronic diseases, such as liver disease, 
accounted for 23% of such discharges, while 
other chronic conditions, including alcohol 
dependence, accounted for 64%. Acute alcohol-
related conditions were more common among 
younger people, whereas chronic diseases and 
other chronic conditions were more prevalent 
among the older age groups.









   












Alcoholic liver disease discharges
The number of discharges with a diagnosis of 
alcoholic liver disease has increased by 221% 
since 1995, to 90.8 per 100,000 persons. The 
increase was most pronounced among those 
aged 15–34 years and those aged 65 years 
or over. Of all discharges with a diagnosis of 
alcoholic liver disease, 8.4% died while in 
hospital.
Partially alcohol-attributable conditions
Between 2012 and 2017, there were 121,919 
hospital discharges from partially alcohol-
attributable conditions. In 2017, there were 
20,201 hospital discharges due to partially 
alcohol-attributable conditions.
Males accounted for 87% of these discharges. 
Although females accounted for just 13% of all 
partially alcohol-attributable hospital discharges 
in 2017, more than one-third (37%) of alcohol 
attributable cancer discharges were female. 
This is primarily due to the high number of 
breast cancer discharges related to alcohol. The 
number of partially alcohol-attributable hospital 
discharges reported in this overview represent 
the minimum number of hospital discharges 
related to alcohol use; the true number is likely 
to be considerably higher.
Alcohol mortality
Between 2008 and 2017, there were 10,803 
alcohol-related deaths recorded on the National 
Drug-Related Deaths Index (NDRDI): 8,000 male 
and 2,803 female. In 2017, there were 1,094 
deaths recorded (see Figure 4).
In 2018, some 30% of self-harm cases were 
alcohol related. Alcohol was significantly more 
common in male presentations of self-harm 
(34%) compared with female presentations (27%). 
It was also associated with peaks in hospital 
attendances at night, at weekends, and on public 
holidays.
Alcohol treatment
Between 2013 and 2019, some 53,200 cases 
were recorded on the National Drug Treatment 
Reporting System (NDTRS) as attending for 
treatment with alcohol as their main problem 
drug. Those registered on the National 
Psychiatric Inpatient Reporting System (NPIRS) 
as attending psychiatric inpatient treatment for 
alcohol dependence has decreased by over 60% 
from 2006 (2,767 cases) to 2019 (1,090 cases), 
largely due to a move to outpatient settings for 
such treatment.
Alcohol overview   continued
Figure 3: Alcohol-related hospitalisations
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Alcohol policy response in Ireland
Since the most recent overview in 2016, the 
most important development in alcohol policy 
in Ireland has been the enactment of the Public 
Health (Alcohol) Act 2018. The main provisions of 
the Act include:
• Minimum unit price (MUP): A minimum price 
set at 10 cent per gram of alcohol in the 
product is compulsory.
• Structural separation of alcohol products: 
Physically separating alcohol products from 
other grocery items is compulsory.
• Restrictions around alcohol advertising: 
Restricting content of advertisements, 
involving a 9pm broadcast watershed for 
advertisements on television and radio; a 
ban on advertising alcohol products near 
schools, in parks, on public transport, in train 
and bus stations, and at bus or Luas stops are 
compulsory.
• Labelling of alcohol products: Labelling the 
direct link between alcohol and cancer; the 
number of grams of alcohol in the container; 
the calorie content; and details of a Health 
Service Executive (HSE) website providing 
public health information are compulsory. 
Health warning labels on alcohol products are 
subject to scrutiny at European Union (EU) 
level and have yet to be commenced.
Conclusion
Since the last Alcohol Overview was published 
in 2016, little has changed with regard to alcohol 
consumption and alcohol-related harm. Ireland 
still has a high level of per capita consumption 
and a majority of drinkers in Ireland consume 
alcohol in a manner risky to their health. The 
consequences of drinking patterns in Ireland 
are reflected in the mortality data, which show 
that on average there have been three alcohol-
related deaths every day since 2008. The signing 
into law of the Public Health (Alcohol) Act in 2018 
was an important first step in reducing alcohol-
related harm; however, for real impact, the 
remaining sections need to be implemented in 
full as soon as possible.
Anne Doyle
1 O’Dwyer C, Mongan D, Doyle A and Galvin B (2021) 
Alcohol consumption, alcohol-related harm and 
alcohol policy in Ireland. HRB Overview Series 11. 
Dublin: Health Research Board.  
https://www.drugsandalcohol.ie/33909/ 
Figure 4: Alcohol-related deaths
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Alcohol overview    continued
POLICY AND LEGISLATION
New priorities for the 
British–Irish Council
On 11 March 2021, a ministerial meeting of 
the Misuse of Substances work sector of the 
British–Irish Council (BIC) was held online. The 
Irish Government is the lead administration for 
this strand of work. The meeting was chaired 
by Frank Feighan TD, Minister of State for 
Public Health, Wellbeing and the National Drugs 
Strategy. The meeting was also attended by 
ministers from the Northern Ireland Executive, 
Scotland, Wales, the Isle of Man, Jersey, 
Guernsey, and the British Government.1
British–Irish Council
As described in issue 72 of Drugnet Ireland,2 
BIC was established in 1999 as part of the Good 
Friday Agreement in order to further promote 
positive, practical relationships among the 
people of the islands as well as to provide a 
forum for consultation and cooperation. The 
formal purpose of BIC,3 as outlined in Strand 3 of 
the Agreement, is as follows:
To promote the harmonious and mutually 
beneficial development of the totality of 
relationships among the peoples of these 
islands... The BIC will exchange information, 
discuss, consult and use best endeavours to 
reach agreement on co-operation on matters 
of mutual interest within the competence of 
the relevant Administrations.4
Items covered and actions agreed
The communiqué published following the 
meeting lacks detail on the content of the 
discussions but notes that the ministers 
discussed two key topics:
• Financial mechanisms to reduce the 
consumption of alcohol: Ministers described 
the efforts of member administrations to 
decrease alcohol consumption and agreed 
that there was value in comparing approaches 
and sharing learnings from the emerging 
evidence base.
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• Measure the effectiveness of addiction 
services and harm reduction strategies: 
The importance of effective monitoring 
and evaluation to ensure evidence-based 
policymaking and practice was recognised. 
It was agreed that sharing this diversity of 
knowledge, understanding, experiences, and 
learning across member administrations 
affords a unique resource for enhancing 
monitoring and evaluation.
Five topics were agreed as priorities for the 
group’s work moving forward:
• Consider the lessons of Covid-19 and the 
delivery of drug and alcohol services.
• Reduce the risk of drug-related deaths.
• Reduce alcohol-related harms through the 
use of financial mechanisms.
• Consider joined-up approaches to meeting 
the health and social needs of people who 
are homeless and use drugs and alcohol 
(in conjunction with the BIC Housing work 
sector).
• Engage with the voluntary and community 
sectors to consider their role in the provision 
of drug and alcohol services, and in the 
development and monitoring of policy.
No further detail was available on what this work 
would entail.
Lucy Dillon
1 British–Irish Council (2021) Ministerial meeting of 
the Misuse of Substances work sector: 11 March 
2021 communiqué. Edinburgh: British–Irish Council. 
https://www.drugsandalcohol.ie/33916/
2 Dillon L (2020) British–Irish Council in Dublin. 
Drugnet Ireland, 72 (Winter): 5.  
https://www.drugsandalcohol.ie/31712/
3 Further details on the work of BIC is available from 
its website: https://www.britishirishcouncil.org/









In August 2020, the Law Reform Commission 
(LRC) published a report on suspended 
sentences.1 The report, which was carried out as 
part of the Fourth Programme of Law Reform, 
examines how the principles of suspended 
sentences are operated and applied in Ireland. 
It builds on the LRC 2017 document, Issues 
paper: Suspended sentences.2 The overall aim 
of the report is to improve and supplement 
these principles from a practical and procedural 
perspective (p. 11).1 
Suspended sentences
A suspended sentence is a prison sentence 
which is not applied for a specified period on 
the condition that the individual who receives 
it adheres to the terms on which the sentence 
was suspended (p. 11). There are two kinds of 
suspended sentences:
• Fully suspended, where the individual may 
never undertake custody if he/she adheres 
to the conditions of the suspended sentence 
fully.
• Part-suspended, which involves two steps, 
time spent in prison followed by ‘conditional 
liberty’ time where the terms of part 
suspension must be adhered to (p. 11). 
Statutory framework
Prior to the enactment of appropriate legislation, 









   












Ireland was evident in common law. Since 2006, 
two pieces of legislation provide for suspended 
sentences in Ireland. Initially, the Criminal Justice 
Act 2006 provided a statutory footing for the 
operation of suspended sentences. Section 
99 provided an outline of the main steps for 
dealing with reoffending and any breaches of the 
conditions when the suspension is in operation. 
The High Court deemed aspects of Section 99 
unconstitutional in 2016 (p. 25). This decision 
resulted in the enactment of the Criminal 
Justice (Suspended Sentences of Imprisonment) 
Act 2017, which amended and clarified several 
procedural issues in Section 99.
Hierarchy of criminal penalties
In the report, the LRC considers where the 
suspended sentence is positioned on the 
hierarchy of criminal penalties in relation to Irish 
law. Part and fully suspended sentences come 
second and third on this hierarchy (see Table 1).
Drugs crime
There are two types of minimum sentences that 
can be provided for drugs crime:
• Mandatory minimum sentence: Here a court 
is required to impose in all cases a minimum 
sentence expressed in years of imprisonment. 
• Presumptive minimum sentence: Here a 
court is still required to impose a minimum 
imprisonment term for conviction of a guilty 
plea, however, the court is also permitted 
to consider exceptional and specific 
circumstances which may justify a ‘depart 
downwards’ (p. 150) by the court. Presumptive 
minimum sentences are prescribed under 
the Misuse of Drugs Act 1977 and the Firearms 
Acts. In its 2013 report3 on mandatory 
sentences, the LRC called for presumptive 
minimum sentences to be repealed and 
replaced with a more structured sentencing 
system. Their views were also acknowledged 
in the 2014 report4 of the Strategic Review 
Group on Penal Policy; however, to date these 
provisions have not been repealed. 
Suspended sentences   continued Under the Misuse of Drugs Act 1977, there are 
two offences where a presumptive minimum 
sentence can be applied: Section 15A provides 
for possession offences and Section 15B provides 
for importation offences. Under Section 27(3C), 
both carry a presumptive minimum sentence of 
10 years' imprisonment (p. 151). When deciding 
whether to implement a presumptive minimum 
sentence, a sentencing judge can take other 
factors into consideration, such as when and 
how the offender pleaded guilty and whether the 
offender helped in the investigation. Previous 
drug trafficking offences are also considered and 
whether it is in the public interest to impose a 
lesser sentence. There must also be exceptional 
and specific circumstances to depart from a 
presumptive sentence.  
Recommendations
Several recommendations were put forward by 
the LRC in the report that aim to supplement and 
improve the principles that have emerged though 
Irish case law.5 These are:
• Judicial discretion: The LRC has 
recommended that the statutory discretion 
given to sentencing judges when selecting 
conditions of suspension and the duration of 
the suspended sentence operational period 
should be maintained. However, these need to 
be proportionate and reasonable such that the 
offender is able to comply.
• Data management and analysis: The LRC 
has recommended that relevant justice 
agencies should have the necessary resources 
to establish a dedicated data management 
and analysis unit. This would allow for the 
collection, collation, and dissemination of data 
related to the overall criminal justice system 
but also the operation of the suspended 
sentence.
• Information and communication technology 
(ICT) architecture within the criminal justice 
system: While there are several initiatives 
enhancing collaboration and cooperation 
between agencies within the Irish criminal 
justice system, the LRC has recommended an 
examination of ICT systems supporting court 
processes and has called for the modernisation 
and streamlining of these systems to enhance 
interoperability and efficiency.
11
Issue 78  |  Sum
m




This constitutes the most severe penalty under Irish law.
2 Part-suspended 
sentence
This is a two-phased sentence: 
1. An immediate custodial sentence followed by
2. A period of 'conditional liberty', where offender adheres to part 
suspension terms
3 Fully suspended 
sentence
The prison sentence has been imposed but immediately 
suspended subject to adherence to the terms of suspension. 
Breaches of conditions result in imprisonment. Suspension can be 
applied to sentences of any length except mandatory sentences.
4 Deferred sentence This shares similarities with the fully suspended sentence but 
they are not the same. Unlike the fully suspended sentence, the 
sentence is specified but not imposed unless deferral conditions 
are breached.
5 Community service 
order
The community service order (CSO) is similar to the fully 
suspended sentence in that it is aimed at controlling future 
offending behaviour. However, in contrast, the CSO is viewed as an 
alternative to prison and is restricted to a range of undemanding 
conditions. A CSO may involve unpaid work limited to 240 hours.
6 Fine A sentencing court can impose a fine for any criminal offence 
punishable by fine or imprisonment or both. A heavy fine is 
considered punitive. The offender's financial means and the 
principle of proportionality are considered when deciding the 
amount of the fine. 
7 Conditional discharge A conditional discharge aims to control future offending behaviour 
and imposes positive obligations on the offender (p. 35).
8 Dismissal In a dismissal order under Section 1(1) of the Probations of 
Offenders Act 1907, the court is allowed to dismiss the charge 
even when it is proven that the offender is guilty. This is viewed as 
the least severe penalty.  
Table 1: Findings of LRC 2020 study, by theme
Suspended sentences   continued
• Sentencing guidance: Finally, the LRC has 
recommended that sentencing guidance for 
suspended sentences, specifically in relation 
to offenders and offences, be prepared by 
the Sentencing Guidelines and Information 
Committee, which was established under the 
Judicial Council Act 2019.
A summary of all recommendations can be found 
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European drug  
report, 2021
The European Monitoring Centre for Drugs 
and Drug Addiction (EMCDDA) published 
the European drug report 2021: trends and 
developments1 on 9 June 2021. The purpose 
of this report is to provide an overview and 
summary of the European drug situation up 
to the end of 2020. The analysis offered in the 
report must be regarded as preliminary due to 
the impact of Covid-19. The Health Research 
Board (HRB) provides the Irish data and research 
for the EMCDDA report.
Latest data
• Around 83 million or 28.9% of adults (aged 
15–64 years) in the European Union (EU) are 
estimated to have used illicit drugs at least 
once in their lifetime.
• The most commonly tried drug is cannabis 
(47.6 million males and 30.9 million females).
• Much lower estimates are reported for the 
lifetime use of cocaine (9.6 million males and 
4.3 million females), MDMA (6.8 million males 
and 3.5 million females), and amphetamines 
(5.9 million males and 2.7 million females).
• Levels of lifetime use of cannabis differ 
considerably between countries, ranging 
from around 4% of adults in Malta to 45% in 
France.
• Last-year drug use provides a measure of 
recent drug use and is largely concentrated 
among young adults. An estimated 17.4 million 
young adults (aged 15–34 years) used drugs in 
the last year (16.9%), with about twice as many 
males (21.6%) as females (12.1%) reporting 
doing so.
• The prevalence of high-risk opioid use among 
adults (aged 15–64 years) is estimated at 
0.35% of the EU population, equivalent to 1 
million high-risk opioid users in 2019.
• There were 510,000 clients in opioid 
substitution treatment in 2019 in the EU. 
Opioid users accounted for 26% of drug 
treatment requests.
• It is estimated that at least 5,141 overdose 
deaths, involving illicit drugs, occurred in the 
EU in 2019, representing an increase of 3% 
compared with 2018.
• Although injecting drug use has been 
declining in Europe for the past decade, it 
remains a major cause of drug-related harms.
• Opioids were involved in 76% of the fatal 
overdoses reported in the EU for 2019.
Covid-19
All routine indicators suggest that at the 
beginning of 2020 there was widespread 
availability of a diverse range of drugs of 
increasingly high purity or potency on the 
European drug market. Drug production and 
trafficking appears to have adapted rapidly to 
pandemic-related restrictions, and there is little 
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evidence of any major disruptions in supply. Drug 
traffickers have adapted to travel restrictions and 
border closures with more reliance on smuggling 
via intermodal containers and commercial supply 
chains and less reliance on the use of human 
couriers. This is illustrated by the large seizures 
of cocaine and other drugs observed during 
2020. Multi-tonne seizures of cocaine were 
reported in European ports in 2020 and early 
2021, including 16 tonnes in Hamburg in Germany 
and 7.2 tonnes in Antwerp in Belgium. Although 
street-based retail drug markets were disrupted 
during the initial lockdowns, and some localised 
shortages were experienced, drug sellers and 
buyers appear to have adapted by increasing 
their use of encrypted messaging services, social 
media applications, online sources, and mail and 
home delivery services.
Information in 2021 suggests that reductions in 
drug consumption during the initial lockdowns 
are being reversed as social distancing 
measures reduce. Online surveys indicate less 
consumer interest in drugs usually associated 
with recreational events, such as MDMA, and 
greater interest in drugs linked with home 
use, such as LSD and 2C-B (2,5-dimethoxy-4-
bromophenethylamine), and dissociative drugs 
such as ketamine.
Technology has also created opportunities for 
responding to drug problems. We can see this 
in the way that many drug services in Europe 
have also demonstrated resilience by adopting 
telemedicine approaches. While some services 
for those with drug problems have been 
disrupted due to the pandemic, the care sector 
has also adapted rather quickly, where services 
were able to introduce innovative working 
practices to mitigate the impact of the current 
crisis on their clients.
Diversity in supply and use of drugs
The patterns of use are becoming more complex, 
with people who use drugs being presented with 
a greater selection of substances. This is creating 
various health harms because of the use of 
more novel substances or from the interaction 
of multiple substances. Some countries are 
seeing an increase in crack cocaine availability 
and use. There are reports of the availability of 
smaller doses or cheaper packages of heroin, 
crack, and benzodiazepines. Benzodiazepines, 
either diverted from therapeutic use or 
not licenced for medical use in Europe, are 
appearing on the illicit drug market. Increased 
use of benzodiazepines was seen among high-
risk drug users, prisoners, and some groups of 
recreational drug users, potentially reflecting the 
high availability and low cost of these substances 
and pandemic-related mental health issues.
New forms of cannabis and new ways of 
consuming them have emerged. There is 
increasing availability of high-potency products. 
Reports indicate that cannabis cultivation 
and synthetic drug production within the EU 
continued at pre-pandemic levels during 2020. 
The picture is complicated by highly potent 
synthetic cannabinoids, which have often been 
used to adulterate natural cannabis products.
Drug use prevalence and trends
Cannabis is the most commonly used drug – its 
prevalence is about five times that of other 
substances. While the use of heroin and other 
opioids remains relatively rare, these continue to 
be the drugs most commonly associated with the 
more harmful forms of use, including injecting. 
The extent of stimulant use and the types that 
are most common vary across countries, yet 
evidence is growing of a potential increase in 
stimulant injecting.
Brian Galvin
1 European Monitoring Centre for Drugs and Drug 
Addiction (EMCDDA) (2021) European drug report 
2021: trends and developments. Luxembourg: 
Publications Office of the European Union.  
https://www.drugsandalcohol.ie/34349/









   













Impact of Covid-19 
on drug and alcohol 
services and people 
who use drugs in 
Ireland: a report of 
survey findings
In January 2021, the Irish Government Economic 
and Evaluation Service (IGEES) published a 
report on the impact of the pandemic on 
services and people who use drugs.1 The report 
was prepared by staff in the Research Services 
and Policy Unit and Health Analytics Division 
in the Department of Health on behalf of the 
department’s Drugs Policy and Social Inclusion 
Unit. The report is based on two surveys 
undertaken in 2020. An article outlining the 
findings of the first survey, the Mini-European 
Web Survey on Drugs: Covid-19, was published 
in issue 76 of Drugnet Ireland.2 Data collection 
for the second, the Survey of Drug and Alcohol 
Services, was completed via an online survey and 
by email between August and September 2020.1
The Survey of Drug and Alcohol Services was 
undertaken to assess the impact of Covid-19 on 
these services. In particular, the survey sought 
to capture how services have altered their 
operations in response to the pandemic and 
also to describe the effect on clients of services. 
Information on this final aspect of the survey was 
provided by services staff and service users were 
not directly involved in the survey. An invitation 
to participate in the survey was sent to over 500 
email addresses for drug and alcohol services in 
Ireland and participants were given two and half 
weeks to complete the survey. 
A total of 157 completed responses were 
submitted. Community Drugs Projects (n=86), 
family support services (n=53), and counselling 
services (n=50) were well represented, 
particularly those based in Dublin.  Some 
respondents can be included in more than 
one of these categories. There were also 
responses from Drug and Alcohol Task Forces, 
low threshold services, peer support services, 
HSE Addiction Services, residential services, and 
general practitioners. 
Effects of Covid-19 on clients
Regarding the direct effects of Covid-19, some 
44 (28%) respondents said that clients were 
highly impacted by having to self-isolate or 
cocoon; 10 (7%) said a diagnosis of Covid-19 
had highly impacted clients; with 4 (3%) saying 
that hospitalisation had had a high impact. The 
majority of services (n=133, 85%) had some 
experience of clients self-isolating in wave 1 of 
the pandemic, while just under one-half were 
aware of clients who had been diagnosed with 
Covid-19. 
According to respondents, the most challenging 
aspects of the pandemic for clients were 
adhering to the restrictions concerning meeting 
people, self-isolating, restrictions on travel, and 
physical distancing. The majority of services 
responding (n=149, 96%) reported a negative 
impact on clients’ mental health, followed by the 
impact on family relationships (n=129, 83%). The 
numbers reporting a positive impact as a result 
of these factors was very small. Other negative 
effects reported by a majority of services were 
the physical health and financial situation of 
clients.
Most services (n=113, 77%) reported that social 
isolation impacted on clients to some extent, 
while 114 services (74%) said that increased 
domestic violence impacted on clients. Most 
services were also aware of the impact of 
increased drug-related intimidation and violence 
and increased overdoses. Fewer services (n=56, 
37%) reported drug-related deaths among those 
using their services. Regarding the effect of the 
pandemic on particular population groups, 65% 
of services who responded said among those 
who were homeless that health and wellbeing 
was highly impacted, while 60% of services said 
women were highly impacted.
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Increased alcohol consumption among clients 
was observed by 68% (n=104) of services, while 
42% (n=61) of services reported increased drug 
use, with just 8% (n=14) reporting a reduction in 
drug use among clients. In relation to availability 
of drugs, 73% (n=108) of respondents had heard 
reports that clients were having difficulty getting 
drugs and had greater use of novel methods 
of acquisition such as online purchases, ‘drug 
drops’, and home deliveries.
Impact on services
Most of the survey respondents (n=116, 74%) said 
that their services had been highly impacted 
by Covid-19, with 25% (n=40) reporting lower 
levels of impacts. Nearly one-half of the services 
responding (n=70, 46%) said the numbers using 
their services had increased. Overall, harm 
reduction services had decreased for clients, 
with just 33% reporting increases. The majority 
of service types saw a reduction in face-to-face 
contact with clients. This was particularly true 
for Drug and Alcohol Task Forces, family support 
services, and peer support services. Most 
services are providing counselling and other 
supports by telephone or online. Residential 
treatment services were the type of service most 
likely to use video conferencing, an appropriate 
tool for group therapy sessions. 
Drug and alcohol services adapted to a reduction 
in face-to-face contact, travel restrictions, and 
social distancing by prioritising the continuity of 
care for those who are opioid dependent; faster 
processing of clients into treatment; stabilisation 
of drug use in isolation; and providing Covid-19 
prevention information as part of outreach 
services. Clients were enabled to access their 
medications by new methods provided under 
temporary changes to regulations and the vast 
majority of services have developed new ways 
of engaging with clients and providing for their 
needs. 
The survey of services outlines the impacts of 
the Covid-19 pandemic on service capacity, 
staff, operations, and governance and reporting. 
Services described how they adapted to the 
challenges and communicated with their clients 
online or by telephone. There was detailed 
information on the typical responses of health 
services to the pandemic, including use of 
personal protective equipment and social 
distancing. Survey findings have also provided an 
indication of the negative impacts the pandemic 
has had on the health and wellbeing of clients 
and on their consumption behaviours.
Brian Galvin
1 Bruton L, Featherstone T and Gibney S (2021) 
Impact of COVID-19 on drug and alcohol services 
and people who use drugs in Ireland: a report of 
survey findings. Dublin: Government of Ireland. 
https://www.drugsandalcohol.ie/34128/ 
2 Mongan D (2021) Impact of Covid-19 on drug use in 
Ireland. Drugnet Ireland, 76 (Winter): 1–7.  
https://www.drugsandalcohol.ie/33957/ 










   











1 Stigma of growing 




Following the opiate epidemic of the 1980s and 
1990s, the United States (US) and many countries 
across Europe have seen a significant increase 
in the proportion of older individuals with a 
drug dependency and those receiving drug 
treatment. In 2017, the European Monitoring 
Centre for Drugs and Drug Addiction (EMCDDA) 
reported that clients over the age of 40 receiving 
methadone maintenance treatment (MMT) had 
increased from 20% to 40% between 2006 and 
2015.1 These trends are also reflected in Irish 
data, with a growing number of clients over the 
age of 35 receiving treatment for opiate use 
since 2009.2
The connection between drug use and the 
experience of stigma and discrimination in 
society is well known. However, there is also a 
growing recognition of stigmatisation against 
opioid agonist therapies, such as MMT, despite 
vast evidence of the public health benefits these 
interventions provide.3,4 In addition, increasing 
age is associated with stigma becoming further 
pronounced; however, with only limited research 
to date, the experiences of those interacting 
with drug treatment services over a prolonged 
timeframe are not well understood.
Stigma, classically defined as an ‘attribute 
that is deeply discrediting’ by Erving Goffman 
in 1963,5 has since been conceptualised on 
three interacting levels: institutional stigma, 
social stigma, and self-stigma. The complex 
and overlapping nature of stigma presents a 
significant barrier to individuals in which negative 
stereotyping at all levels serves to reinforce the 
structural inequalities in place.
In line with similar studies published in the US 
and the United Kingdom (UK) identifying age-
related embarrassment and shame in older 
methadone patients, a 2021 research paper 
by Mayock and Butler, published in the journal 
Drugs: Education, Prevention and Policy, 
examined the intersecting levels of stigma 
experienced by service users who are growing 
older on long-term MMT in Ireland.6
Methods
In-depth qualitative interviews were recorded 
with 25 long-term clients who had been 
enrolled in MMT at least 10 years prior to 
participating in the study. Recruitment was 
guided by a purposive sampling strategy 
within a geographical area of South Dublin 
and focused primarily on clients of specialist 
addiction clinics. An interview schedule of 
topics and questions was prepared in advance 
but maintained flexibility to ensure collected 
data accurately reflected the respondents’ 
personal perspectives. Analysis did not separate 
the sources of stigma in order to reflect the 
interwoven nature of these experiences by study 
participants.
Results
In total, 16 male and nine female clients 
participated in the study, all of whom identified 
as Irish and were of white ethnicity. Greater than 
two-thirds of participants were over the age of 
40 at the time of the research taking place and 
16 of the 25 recruited had accessed MMT more 
than 20 years previously.
Methadone treatment system
While study participants had encountered 
kindness and empathy among some healthcare 
professionals, accounts overall summarised 
the methadone treatment regime to be 
‘demoralising’ and unlike other healthcare 
services. For many, stigma was experienced 
and conveyed through an absence of trust from 
treatment providers and a sense of control 
exerted over the client. Privileges such as 
takeaway doses could be easily withdrawn and 
the requirement to provide urine samples under 
supervision was described by interviewees as 
‘mortifying’ and ‘degrading’. The lack of agency 
and palpable divide felt by clients with their 
treatment professionals served to reinforce 
feelings of inferiority and the perception of 
clients as deviant and a ‘junkie’.
17
Issue 78  |  Sum
m
er 2021     drugnet Ireland      
Secrecy and concealment
For many participants, fear of public scrutiny 
and negative responses from family, friends, and 
the community dictated their behaviour towards 
clinic or pharmacy attendance. The pressure 
to manage public perceptions was reported 
by women, in particular, with one respondent 
explaining how she would ‘go down at a certain 
time knowing that’s the time there won’t be 
many there and I’m in and out in a flash’. Many 
clients felt they were treated differently and had 
experienced public shaming in these settings. 
One interviewee described how she was ‘outed’ 
by a pharmacist due to lack of discretion in 
the presence of a neighbour and felt that ‘the 
ground couldn’t open up fast enough, I just 
wanted to die’.
Participants also believed that revealing their 
status as a methadone patient could jeopardise 
their employment opportunities, and opinions 
expressed in the workplace served to strengthen 
the need for secrecy. As one interviewee 
explained of her colleagues: ‘I’d be afraid for 
them to know. The things they say about drug 
addicts … It wouldn’t go down good.’
Private burden
For study participants, the stigmatising attitudes 
and experiences in their external environment 
had  perpetuated a deep sense of self-stigma 
interwoven with their self-identity. This was 
highlighted by one interviewee who described 
their personal perspective on addiction as ‘that’s 
what you do as a drug addict – you let people 
down, you’re unreliable, you’re of fucking no use 
to nobody’.
Internalised shame also impacted participants’ 
ability to have close relationships or form new 
ones for fear for rejection, with one participant 
describing herself as a ‘junkie in disguise’. Such 
feelings of social isolation and loneliness were 
reinforced further with age, with participants 
already having experienced long periods of 
marginality. Many had resigned themselves to 
being cut off from wider society and felt they 
were now condemned to ostracisation: ‘That 
sort of loneliness is physically painful, as well 
as emotionally, but I just can’t see that ever 
changing.’
Conclusions
This study describes how long-term methadone 
treatment was punctuated by stigma intersecting 
at macro, meso, and micro levels in clients’ 
lives. Methadone use in older patients implicitly 
revealed their histories as drug users and carried 
negative connotations that marked them as 
different to other health service users. The 
authors acknowledge the small sample size and 
selection of participants primarily from specialist 
addiction clinics to be limitations of this work. 
They recommend that future studies engage 
with larger groups and wider treatment contexts. 
Nevertheless, these findings reveal that current 
practices and public perceptions severely hinder 
an improved quality of life for long-term clients 
of MMT.
Emma McGrath
1 European Monitoring Centre for Drugs and Drug 
Addiction (2017) Health and social responses to 
drug problems: a European guide. Luxembourg: 
Publications Office of the European Union.  
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2 Health Research Board National Drugs Library (2017) 
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Board.  
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3 Lloyd C (2013) The stigmatization of problem drug 
users: a narrative literature review. Drugs Educ Prev 
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6 Mayock P and Butler S (2021) ‘I’m always hiding and 
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1 New evidence 
on school-based 
programmes
Schools are an important setting for the delivery 
of prevention and harm reduction interventions 
to adolescents. In April 2021, based on the 
findings of systematic reviews published in 2020, 
the European Monitoring Centre for Drugs and 
Drug Addiction (EMCDDA) updated the evidence 
on its Best Practice Portal (BPP) concerning 
school-based programmes to improve young 
people’s mental health and wellbeing and 
reduce risks related to substance use. They 
relate to school-based multicomponent positive 
psychology interventions (MCPPIs), school anti-
bullying interventions, and e-health school-
based interventions.1,2
Multicomponent positive psychology 
interventions
Positive psychology interventions (PPIs) are 
scientifically based interventions that focus on 
strengthening positive emotions, thoughts, and 
behaviours through activities that can be easily 
implemented in daily routines.3 They focus on 
one component of wellbeing such as gratitude. 
In their simplest terms, MCPPIs differ in that they 
focus on two or more components that target 
both the eudaimonic (wellbeing as the realisation 
of one’s true inner potential and virtue as a 
pathway to experiencing a meaningful and 
fulfilling life) and hedonic (wellbeing as pleasure 
maximisation and pain avoidance) components 
of wellbeing.4 School-based MCPPIs aim to 
increase wellbeing indicators of mental health 
(i.e. subjective and psychological wellbeing) and 
reduce the most common psychological distress 
indicators (i.e. depression, anxiety, and stress) in 
adolescents.
While meta-analyses have shown the efficacy of 
MCPPIs in adult samples, the study of Tejada-
Gallardo et al.3 is the first to investigate the 
effects in adolescents. Through meta-analysis 
they aimed to examine the immediate and 
long-lasting effects of school-based MCPPIs 
aimed at increasing wellbeing (subjective and 
psychological) and reducing psychological 
distress symptoms (depression, anxiety, and 
stress) of pupils from the general population 
aged between 10 and 18 years of age. While all 
of the nine studies (4898 participants) included 
wellbeing outcomes, only four looked at those 
related to psychological distress. Seven of the 
studies were randomised control trials and two 
were non-randomised control trials.
The authors found that MCPPIs can be effective 
in improving subjective (g=0.24, 95% CI: 0.11–
0.38, p=0.000) and psychological (g=0.25, 95% 
CI: 0.01–0.51, p<0.05) wellbeing and reducing 
depression symptoms (g=0.28, 95% CI: 0.13–
0.43, p=0.000) in adolescents. However, no 
effects were found for symptoms of anxiety, 
and effects on stress could not be analysed 
due to a lack of studies looking at this outcome. 
The positive effects on psychological wellbeing 
and depression symptoms were found to have 
remained significant in the long term. Based on 
these findings, the BPP rates these programmes 
as ‘beneficial’ and the authors conclude that:
Multicomponent positive psychology 
interventions offer an opportunity to 
ensure mental health during adolescents’ 
development in schools. Academic policies 
and education practitioners should consider 
the inclusion of these interventions within the 
school curriculum to promote adolescents’ 
mental health and optimal development.  
(p. 1957)3
Anti-bullying interventions
Universal prevention activities target bullying as 
it has high prevalence rates and is associated 
with an increased lifetime prevalence of mental 
health disorders and therefore increase the 
risk of substance use. Two recent systematic 
reviews with meta-analysis have found small yet 
significant effects from these interventions on 
related outcomes. The findings have led the BPP 
to rate these kinds of interventions as ‘likely to 
be beneficial’.
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The first review by Ng et al.4 covered 17 
studies (n=35 694 participants) and found the 
interventions to have very small to small yet 
significant effects in:
• Reducing traditional bullying and 
cyberbullying perpetration (traditional: 
standardised mean differences [SMD]  
–0.30; cyber: SMD –0.16)
• Reducing traditional bullying and 
cyberbullying victimisation  
(traditional: SMD –0.18; cyber: SMD –0.13).
The authors found that programme effectiveness 
was not affected by type of intervention 
(i.e. whole school-based or classroom-
based), programme duration, or presence of 
parental involvement. However, cyberbullying 
programmes were found to be more effective 
when delivered by technology-savvy content 
experts compared with teachers.
The second review by Fraguas et al.5 covered 69 
randomised control trials (111 659 participants). 
They found school anti-bullying interventions to 
have small but significant effects in:
• Reducing bullying (effect size: −0.150; 95%  
CI: −0.191 to −0.109)
• Improving mental health problems  
(effect size: −0.205; 95% CI: −0.277 to −0.133) 
at study end point.
The review also considered the population 
impact number (PIN). In its simplest terms, 
PIN is the number in the whole population 
among whom one case will be prevented by the 
intervention. The review found that an average 
anti-bullying intervention needs to include 147 
(95% CI: 113–213) people to prevent one case of 
bullying; 107 (95% CI: 73–173) people to improve 
mental health problems; and 167 (95% CI: 100–
360) people to prevent one case of cyberbullying 
perpetration or exposure.
e-health interventions
Champion et al.6 carried out a systematic 
review and meta-analysis on the effectiveness 
of eHealth school-based interventions targeting 
multiple lifestyle risk behaviours. They included 
16 studies (n=18 873 participants), which involved 
randomised controlled trials of eHealth (internet, 
computers, tablets, mobile technology, or tele-
health) interventions that targeted two or more 
of the following behaviours: alcohol use, smoking, 
diet, physical activity, sedentary behaviour, and 
sleep. The primary outcomes of interest for the 
meta-analysis were the prevention or reduction 
of unhealthy behaviours, or improvement in 
healthy behaviours of the six behaviours.
While they found some effectiveness in 
improving physical activity, screen time, and 
fruit and vegetable intake, the effects were 
small and only evident immediately after the 
intervention. There was no effect found for 
alcohol use or smoking. These findings led the 
BPP to rate eHealth interventions in school as 
having ‘unknown effectiveness’. The authors 
conclude that ‘further high quality, adolescent-
informed research is needed to develop 
eHealth interventions that can modify multiple 
behaviours and sustain long-term effects’  
(p. e206).
Concluding comment
The EMCDDA continues to draw on new evidence 
to provide stakeholders with an accessible 
and reliable evidence base through the BPP. 
The findings of the MCPPIs are of particular 
interest in the Irish context. The evidence 
suggests support for whole-school prevention 
programmes currently being delivered in Irish 
schools, for example, in Social, Personal and 
Health Education (SPHE) and the Wellbeing 
programme. Rigorous evaluation of these 
programmes would reflect international best 
practice, in line with European Union minimum 
quality standards for prevention, to which Ireland 
signed up:










   












Prevention interventions form part of a 
coherent long-term prevention plan, are 
appropriately monitored on an ongoing basis 
allowing for necessary adjustments, are 
evaluated and the results disseminated so as 
to learn from new experiences.7
Ireland’s school-based prevention programmes 
could make a valuable contribution to the 
evidence base for the effectiveness of such 
interventions.
Lucy Dillon
1 European Monitoring Centre for Drugs and Drug 
Addiction (2021) EMCDDA Best practice portal 
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on well-being and distress — evidence summary. 
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Development of the 
Healthy Addiction 
Treatment recovery 
model for nursing in 
addiction services
Background
The purpose of a nursing model is to define the 
underpinning theory and concepts that guide 
nursing practice. To date, there is no nursing 
model specific to addiction services; however, 
several general models of nursing are frequently 
used in this context. An external review 
undertaken by Strang1 described current models 
used within addiction services internationally 
as task-oriented and reactive, with little time 
available for nurses to work flexibly to client 
need. This contrasts with the understanding 
that service provision should support a person-
centred journey to recovery.
To address this gap, Comiskey et al.2 set out to 
develop an evidence-based addiction nursing 
model based on a cross-sectional survey of 
client needs and by mapping the relevant 
features of current models in practice. The 
proposed nurse-led Heathy Addiction Treatment 
(HAT) model targets health and recovery need at 
the population level, while allowing adaptation to 
local needs and settings.
Methods
The health-related needs of 131 clients receiving 
opiate agonist treatment across six Dublin drug 
treatment clinics were objectively assessed 
using the Opiate Treatment Index (OTI)3,4 
structured interview tool with the General 
Health Questionnaire.5,6 The OTI measures a 
range of attributes across six domains: drug 
use, infectious disease risk, physical health, 
social functioning, criminality, and psychological 
adjustment. A numerical score is calculated 
for each outcome domain, with higher scores 
indicating a higher level of dysfunction. Data 
were collected from the study participants 
between May and November 2017.
In addition, relevant features from established 
nursing models were identified and mapped by 
an expert practice group through a formative 




Of the 131 clients that participated in the study, 
66% were male and 34% were female, with a 
mean age of 41 years. All participants were on a 
substitution treatment programme with a median 
treatment duration of six years. Both men and 
women self-reported using heroin and cocaine 
on average more than once a week and polydrug 
use occurred more than once a day in the 30 
days prior to interview. The most common 
physical symptoms reported by both genders 
were fatigue and energy loss, with about 70% 
of men and about 80% of women experiencing 
these health symptoms. Notably, the study 
reported a mean psychological adjustment score 
of 11.07 for women and 7.59 for men. Given the 
recommended cut-off point in this outcome 
domain is a score of 4, mental health was 
therefore identified as a priority need for clients 
in addiction nursing services.
Nursing models
A review of current nursing models by expert 
practitioners determined that elements of three 
key models were relevant to the development 
of the addiction nursing model in this study. 
The group proposed to draw from the BRENDA 
model,7 which represents a biopsychosocial 
approach of medical management combined 
with a series of short and structured discussions 
between the client and practitioner; the FRAMES 
model,8 which focuses on brief interventions to 
initiate behavioural change in a single measurable 
outcome; and the Tidal model,9 which works to 
promote mental health and empower clients to 
lead their own recovery.
Healthy Addiction Treatment recovery 
model
Informed by the client assessment outcomes and 
the objective review of seminal nursing models, 
a collaborative nurse-led hybrid model was 
proposed. The conceptual HAT model places 









   












health and recovery need and measuring 
impact at the population level. A manual and 
flowchart were developed for piloting of the 
model in practice and staff were allocated a 
working caseload of volunteering clients. Mental 
health was identified as a priority need for the 
participating client group on development of the 
HAT model; however, for wider implementation 
the model can be adapted and applied to the 
greatest nursing need determined in varied client 
cohorts and environments.
Conclusion
From this study the authors recommend the first 
nursing model specific to addiction services. 
The HAT recovery model is a practical and 
measurable approach to address objectively 
identified need and can be implemented within 
existing addiction service structures. Greatest 
nursing need is prioritised by directing nursing 
staff time towards client-focused tasks and 
eradicating entrenched practices. As the 
model is implemented over time, services 
can increase capacity in this approach and 
establish procedures and evaluation processes 
contextually appropriate to the local setting.
Emma McGrath
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PREVALENCE AND CURRENT SITUATION
Trends in alcohol and 
drug admissions to 
psychiatric facilities
The annual report published by the Mental 
Health Information Systems Unit of the Health 
Research Board, Activities of Irish psychiatric 
units and hospitals 2019,1 shows that the rate 
of new admissions to inpatient care for alcohol 
disorders has decreased.
In 2019, some 1,090 cases were admitted to 
psychiatric facilities with an alcohol disorder, of 
whom 301 were treated for the first time. Figure 
1 presents the rates of first admission between 
1999 and 2019 for cases with a diagnosis of an 
alcohol disorder. The admission rate in 2019 
was lower than the previous year, and trends 
over time indicate an overall decline in first 
admissions. Approximately one-third (33.6%) of 
cases hospitalised for an alcohol disorder in 2019 
stayed just under one week, while 31.2% of cases 
were hospitalised for between one and three 
months, similar to previous years.
In 2019, some 1,090 cases were also admitted 
to psychiatric facilities with a drug disorder. Of 
these cases, 440 were treated for the first time. 
Figure 2 presents the rates of first admission 
between 1999 and 2019 of cases with a diagnosis 
of a drug disorder. The admission rate in 2019 
was higher than the previous year, and trends 
over time indicate an overall increase in the 
rate of first admission with a drug disorder since 
2011. It should be noted that the report does 
not present data on drug use and psychiatric 
comorbidity; it is therefore not possible to 
determine whether or not these admissions  
were appropriate.
Figure 1: Rates of psychiatric first admission of cases with a diagnosis of an alcohol disorder per 
100,000 of population in Ireland, 1999-2019











































































   












Other notable statistics on admissions for a drug 
disorder in 2019 include the following:
• Less than one-half of cases hospitalised for a 
drug disorder stayed under one week (49.8%), 
while 98.7% were discharged within three 
months. It should be noted that admissions 
and discharges represent episodes or events 
and not persons.
• 17.3% of first-time admissions were 
involuntary.
• Similar to previous years, the rate of first-
time admissions was higher for men (14.7 per 
100,000) than for women (3.9 per 100,000).
Seán Millar
1 Daly A and Craig S (2020) Activities of Irish 
psychiatric units and hospitals 2019 main findings. 
Dublin: Health Research Board.  
https://www.drugsandalcohol.ie/32386/
Admissions to psychiatric 
facilities   continued
Figure 2: Rates of psychiatric first admission of cases with a diagnosis of a drug disorder per 
100,000 of population in Ireland, 1999-2019
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The annual report from National Self-Harm 
Registry Ireland was published in 2020.1 The 
report contains information relating to every 
recorded presentation of deliberate self-harm 
to acute hospital emergency departments in 
Ireland in 2019 and complete national coverage 
of cases treated. All individuals who were alive on 
admission to hospital following deliberate self-
harm were included, along with the methods of 
deliberate self-harm that were used. Accidental 
overdoses of medication, street drugs, or alcohol 
were not included.
Rates of self-harm
There were 12,465 recorded presentations of 
deliberate self-harm in 2019, involving 9,705 
individuals. Taking the population into account, 
the age-standardised rate of individuals 
presenting to hospital in the Republic of Ireland 
following self-harm was 206 per 100,000 
population. This was a decrease of 2% compared 
with the rate recorded in 2018 (210 per 100,000) 
and 8% lower than the peak rate recorded by the 
registry in 2010 (223 per 100,000).
In 2019, the national male rate of self-harm 
was 187 per 100,000 population, 3% lower than 
in 2018. The female rate was 226 per 100,000 
population, which was 1% lower than in 2018. 
With regard to age, the peak rate for men was 
in the 20-24 age group, at 485 per 100,000 
population. The peak rate for women was among 
15-19-year-olds, at 726 per 100,000 population.
Self-harm and drug and alcohol use
Intentional drug overdose was the most common 
form of deliberate self-harm reported in 2019, 
occurring in 7,763 (62.3%) of episodes. As 
observed in 2018, overdose rates were higher 
Figure 1: Person-based rate of deliberate self-harm from 2002 to 2019 by gender
Source: National Suicide Research Foundation (2020)
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High rates of self-harm are consistently seen 
among young people in Ireland and other 
countries. The incidence of hospital-presenting 
self-harm peaks among young people, who most 
often engage in intentional drug overdose (IDO). 
In addition, the risk of self-harm repetition is 
also high among young people, with several 
countries reporting increases in youth self-harm 
since 2017.1,2,3 These trends are of concern, 
considering the association between self-harm 
and increased risk of suicide in young people, 
with repeated self-harm further elevating this 
risk. However, little is known about patterns of 
repetition and method-switching following IDO 
among young people.
An Irish study4 from 2020 investigated repeated 
self-harm and method-switching following 
hospital-presenting IDO among young people. 
In this research, published in the International 
Journal of Environmental Research and Public 
Health, data from National Self-Harm Registry 
Ireland on hospital-presenting self-harm by 
individuals aged 10–24 years during 2009–2018 
among women (67.1%) than among men (56.3%). 
Minor tranquillisers and major tranquilisers were 
involved in 33% and 9% of drug overdose acts, 
respectively. In total, 34% of male and 48% of 
female overdose cases involved analgesic drugs, 
most commonly paracetamol, which was involved 
in 31% of all drug overdose acts. In 69% of cases, 
the total number of tablets taken was known, 
with an average of 28 tablets taken in episodes of 
self-harm that involved a drug overdose.
In 2019, there was an increase in the number 
of self-harm presentations to hospital involving 
street drugs by 17% (from 742 to 870). Since 
2007, the rate per 100,000 of intentional drug 
overdose involving street drugs has increased by 
79% (from 9.9 to 17.8 per 100,000 population). 
Cocaine and cannabis were the most common 
street drugs recorded by the registry in 2019, 
present in 7% and 3% of overdose acts, 
respectively. Cocaine was most common among 
men, involved in 19% of overdose acts by 
25-34-year-olds. Cannabis was most common 
among men aged 15-24 years and was present 
in 10% of overdose acts. Alcohol was involved in 
31% of all self-harm presentations in 2019 and 
was more often involved in male episodes of 
self-harm than female episodes (36% vs 28%, 
respectively).
Recommendations
In 2019, there was a significant increase in 
presentations among persons experiencing 
homelessness, which is in line with previous 
trends identified in the period 2010-2014. 
The report authors noted that this group of 
individuals represent a particularly vulnerable 
population - at high risk of repetition and 
mortality from all causes. Although further work 
which examines factors associated with self-
harm among persons experiencing homelessness 
is required, the authors suggest these findings 
underline the need for targeted suicide 
prevention interventions among this group.
Seán Millar
1 Joyce M, Daly C, McTernan N, et al. (2020) National 
Self-Harm Registry Ireland annual report 2019. 
Cork: National Suicide Research Foundation.  
https://www.drugsandalcohol.ie/33511/
National Self-Harm Registry 
report, 2019   continued
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were examined. Cox proportional hazards 
regression models with associated hazard ratios 
(HRs), survival curves, and Poisson regression 
models with risk ratios (RRs) were used to 
examine the risk factors for repetition and 
method-switching.
Results
During the period 2009–2018, some 16,800 
young people presented following IDO. Of these 
hospital presentations, within 12 months, 2,136 
young people repeated self-harm. Factors 
associated with repetition included being male 
(HR=1.13, 95% CI: 1.03–1.24); being aged 10–17 
years (HR=1.29, 95% CI: 1.18–1.41); consuming 50 
or more tablets (HR=1.27, 95% CI: 1.07–1.49); and 
taking benzodiazepines (HR=1.67, 95% CI: 1.40–
1.98) or antidepressants (HR=1.36, 95% CI: 1.18–
1.56). The cumulative risk for switching method 
was 2.4% (95% CI: 2.2–2.7). Method-switching 
was most likely to occur for males (RR=1.36; 95% 
CI: 1.09–1.69) and for those who took illegal drugs 
(RR=1.63; 95% CI: 1.19–2.25).
Conclusions
The authors discussed how young males were 
at increased risk of both repetition following 
IDO and method-switching – often to more 
potentially lethal methods of self-harm and 
that benzodiazepines and illegal drugs were 
associated with risk of repetition and method-
switching among young people. They suggest 
that ensuring the provision of mental health 
assessments and regulating drug access are 
key action areas for the prevention of suicidal 
behaviour among young people.
Seán Millar
1 Griffin E, McMahon E, McNicholas F, Corcoran P, 
Perry IJ and Arensman E (2018) Increasing rates of 
self-harm among children, adolescents and young 
adults: a 10-year national registry study 2007–2016. 
Soc Psychiatry Psychiatr Epidemiol, 53: 663–671. 
https://www.drugsandalcohol.ie/29041/
2 Tyrrell EG, Orton E, Sayal K, Baker R and Kendrick 
D (2017) Differing patterns in intentional and 
unintentional poisonings among young people in 
England, 1998–2014: a population-based cohort 
study. J Public Health (Oxf), 39(2): e1–e9.
3 Cairns R, Karanges EA, Wong A, et al. (2019) Trends 
in self-poisoning and psychotropic drug use in 
people aged 5–19 years: a population-based 
retrospective cohort study in Australia. BMJ Open, 
9(2): e026001.
4 Daly C, Griffin E, McMahon E, et al. (2020) Repeat 
self-harm following hospital-presenting intentional 
drug overdose among young people – a national 
registry study. Int J Environ Res Public Health, 17(17): 
6159. https://www.drugsandalcohol.ie/32865/









   














standards in drug 
demand reduction
The Civil Society Forum on Drugs (CSFD) is an 
expert group of civil society organisations (CSOs) 
in the European Commission that supports 
the commission in its drug policy formulation 
and implementation.1 One of its four working 
groups focuses on supporting and promoting 
the European Union’s (EU) 2015 minimum 
quality standards in drug demand reduction.2 In 
January 2020, CSFD published its guidelines and 
recommendations for the implementation of 
minimum quality standards by CSOs,3 followed in 
2021 by a CFSD advocacy plan for the promotion 
and implementation of minimum quality 
standards in drug demand reduction.4
Civil Society Forum on Drugs
The CSFD comprises 45 CSOs from across 
Europe. Ireland is represented by the Ana 
Liffey Drug Project and the CityWide Drugs 
Crisis Campaign. The group is described as 
‘representing a variety of fields of drug policy, 
and a variety of stances within those fields’.1 The 
purpose of the group is to facilitate a structured 
dialogue between the commission and European 
civil society to support drug policy formulation 
and implementation through practical advice. To 
meet this aim, CSFD is made up of four working 
groups, each of which focuses on a particular 
policy area: the EU Action Plan on Drugs; 
relations with international institutions; civil 
society involvement with national drug policies; 
and minimum quality standards. The focus of this 
article is on the work of the fourth group.
Minimum quality standards in drug 
demand reduction
The Council of the EU conclusions on the 
implementation of the EU Action Plan on 
Drugs 2013–2016 regarding minimum quality 
standards in drug demand reduction in the 
EU2 were adopted by the council in 2015. It 
identified 16 quality standards to be met across 
the EU by drug demand reduction interventions 
in prevention; risk and harm reduction; and 
treatment, social integration, and rehabilitation. 
These standards are shown in Box 1 (overleaf). 
While there is no legal obligation on national 
governments to meet these standards, it is 
argued by the CSFD that they represent ‘the 
political will of EU countries to address demand 
reduction interventions through an evidence-
based perspective’ (p. 4).3
Guidelines for quality standards
The CSFD working group on minimum quality 
standards has as its objectives to promote the 
implementation of the standards in EU member 
states (advocacy) and to improve knowledge  
and skills among CSOs on how to implement  
the standards at national level. Two of the 
activities carried out by the group to meet  
these objectives were:
• To develop and apply an assessment tool 
through which CSOs could monitor and assess 
the implementation of the standards in their 
own countries and organisations
• To examine the feasibility of implementing  
the standards among CSOs.
In January 2020, the group published a set 
of guidelines and recommendations for the 
implementation of the standards grounded in  
the earlier work of the group. The publication 
aims to support CSOs working in the drug 
demand reduction field to:
• Assess and implement their interventions 
according to the standards
• Identify potential barriers for incorporation
• Assess the potential need to provide training 
for practitioners and developers in the drug 
demand reduction field in line with these 
standards.
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Drug demand reduction   continued
Box 1: Minimum quality standards in drug demand reduction
I. Prevention
(a) Prevention (environmental, universal, selective, and indicative) interventions are targeted at 
the general population, at populations at risk of developing a substance use problem or at 
populations/individuals with an identified problem. They can be aimed at preventing, delaying 
or reducing drug use, its escalation, and/or its negative consequences in the general population 
and/or subpopulations; and are based on an assessment of and tailored to the needs of the 
target population.
(b) Those developing prevention interventions have competencies and expertise on prevention 
principles, theories, and practice, and are trained and/or specialised professionals who have the 
support of public institutions (education, health, and social services) or work for accredited or 
recognised institutions or NGOs (non-governmental organisations).
(c) Those implementing prevention interventions have access to and rely on available evidence-
based programmes and/or quality criteria available at local, national, and international levels.
(d) Prevention interventions form part of a coherent long-term prevention plan, are appropriately 
monitored on an ongoing basis, allowing for necessary adjustments, are evaluated, and the 
results disseminated so as to learn from new experiences.
II. Risk and harm reduction
(a) Risk and harm reduction measures, including but not limited to measures relating to infectious 
diseases and drug-related deaths, are realistic in their goals, are widely accessible, and are 
tailored to the needs of the target populations.
(b) Appropriate interventions, information, and referral are offered according to the characteristics 
and needs of the service users, irrespective of their treatment status.
(c) Interventions are available to all in need, including in higher risk situations and settings.
(d) Interventions are based on available scientific evidence and experience and provided by 
qualified and/or trained staff (including volunteers), who engage in continuing professional 
development.
III. Treatment, social integration, and rehabilitation
(a) Appropriate evidence-based treatment is tailored to the characteristics and needs of service 
users and is respectful of the individual’s dignity, responsibility, and preparedness to change.
(b) Access to treatment is available to all in need upon request, and not restricted by personal or 
social characteristics and circumstances or the lack of financial resources of service users. 
Treatment is provided in a reasonable time and in the context of continuity of care.
(c) In treatment and social integration interventions, goals are set on a step-by-step basis and 
periodically reviewed, and possible relapses are appropriately managed.
(d) Treatment and social integration interventions and services are based on informed consent,  









   












The guidelines are structured around the 
standards. Under each standard, the key findings 
of the assessment tool and feasibility analysis 
exercises are noted. Recommendations are then 
made for CSOs to consider when implementing 
that standard. For example, under prevention 
standard 3 on interventions being evidence 
based (see Box 1), it was found that this standard 
was poorly implemented both at the member 
state and CSO levels. There were almost no 
registries of evidence-based interventions 
found at national, regional or local level across 
member states. However, even where registries 
existed at an international level (e.g. the Xchange 
registry of the European Monitoring Centre for 
Drugs and Drug Addiction5), they were not being 
used to inform decisions about interventions. 
The guidelines recommend that CSOs draw on 
these registries as an integral element of their 
work and discuss them as a routine part of staff 
induction and training. Funders should require 
the CSO to provide evidence that any proposed 
intervention is consistent with good practice on 
registries such as Xchange.
Recommendations for improving quality
The guidelines provide a valuable overview of 
the situation in member states and illustrate 
the many ways in which they and their CSOs 
are failing to meet the minimum standards. Its 
conclusion captures four cross-cutting themes 
that best illustrate areas in urgent need of 
improvement.
• Disinvestment from ineffective and harmful 
interventions: Interventions which are known 
to be ineffective or even harmful for target 
populations continue to be funded across the 
EU. This is especially a feature in the fields 
of prevention and risk and harm reduction. 
Resources should be redirected towards 
the implementation of evidence-based and 
effective interventions.
• Education and training, and continuing 
professional development: A recurring 
theme throughout the report is a gap in 
quality education, training, and continuing 
professional development for the drug 
demand reduction workforce. This was 
found to be particularly acute in the fields of 
prevention and risk and harm reduction. It is 
recommended that governments and CSOs 
invest more resources in filling this gap.
• Monitoring and evaluation: The authors 
conclude that ‘the evaluation culture is 
weak in Europe in the field of drug demand 
reduction’ (p. 23).3 They argue for a balance in 
approach, whereby evaluation and monitoring 
become an integrated part of delivery but 
which do not take away from the delivery of 
quality services. Monitoring and evaluation 
would improve the quality of interventions 
and would motivate professionals delivering 
work found to be of good quality.
Drug demand reduction   continued
(e) Treatment is provided by qualified specialists and trained staff who engage in continuing 
professional development.
(f) Treatment interventions and services are integrated within a continuum of care to include, 
where appropriate, social support services (education, housing, vocational training, welfare) 
aimed at the social integration of the person.
(g) Treatment services provide voluntary testing for blood-borne infectious diseases, counselling 
against risky behaviours, and assistance to manage illness.
(h) Treatment services are monitored and activities and outcomes are subject to regular internal 
and/or external evaluation.
Source: Council of the European Union (2015)2 
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• Sustainable funding related to the 
implementation of standards: It was found 
that almost no sustainable funding was 
available to interventions in the field of drug 
demand reduction. It is recommended that 
this be addressed and that funding is linked 
to meeting the minimum quality standards. 
This would create a culture in which the 
knowledge and skills of the workforce and an 
evidence base of effective practice would be 
supported.
CSFD next steps
The CSFD’s work in this area is ongoing. Moving 
forward, the working group is to focus on ‘further 
dissemination and promotion of guidelines and 
recommendations across Europe, advocacy for 
assessment and implementation of standards in 
practice, and development and testing of training 
course for CSOs to improve the implementation 
of standards within civil society sector’ (p. 3).4 
In February 2021, CSFD published an advocacy 
plan for the promotion and implementation 
of minimum quality standards in drug demand 
reduction by CSOs.4 This is a working document 
for the group of CSOs, which lays out specific 
activities that it is undertaking between 2020 
and 2022 to meet their aim of advocating the 
implementation of the standards.
Conclusion
The work of CSFD highlights the need to 
improve quality in drug demand reduction 
interventions and to encourage stakeholders 
to make evidence-based decisions. In Ireland, 
advocacy for the implementation of the 
minimum quality standards needs to involve all 
stakeholders, such as policymakers, funders, 
and service providers, including CSOs. Advocacy 
needs to be complemented with training and 
support for those working in the sector. That 
way they can deliver services that meet these 
standards to ensure the most effective use of 
funding to deliver on the aims of interventions 
in this field. Training might include the European 
Prevention Curriculum (EUPC), which has 
been previously discussed in Drugnet Ireland. 
It is a programme of training, the primary goal 
of which is ‘to reduce the health, social and 
economic problems associated with substance 
use by building international prevention 
capacity through the expansion of the European 
professional prevention workforce’ (p. 10).6
Lucy Dillon
1 For further information on CSFD, visit:  
http://www.civilsocietyforumondrugs.eu/
2 Council of the European Union (2015) Council 
conclusions on the implementation of the EU 
Action Plan on Drugs 2013–2016 regarding minimum 
quality standards in drug demand reduction in the 
European Union. 11985/15. Brussels: Council of the 
European Union.  
https://www.drugsandalcohol.ie/24317/
3 Civil Society Forum on Drugs (2020) Guidelines 
and recommendations for the implementation 
of minimum quality standards by civil society 
organisations (CSOs). Amsterdam: Civil Society 
Forum on Drugs.  
https://www.drugsandalcohol.ie/34040/ 
4 Civil Society Forum on Drugs (2021) CSFD advocacy 
plan for the promotion & implementation of 
minimum quality standards in drug demand 
reduction. Amsterdam: Civil Society Forum on 
Drugs. https://www.drugsandalcohol.ie/33833/
5 For further information on Xchange, visit:  
http://www.emcdda.europa.eu/best-practice/
xchange
6 European Monitoring Centre for Drugs and Drug 
Addiction (EMCDDA) (2019) European prevention 
curriculum: a handbook for decision-makers, 
opinion-makers and policy-makers in science-
based prevention of substance use. Luxembourg: 
Publications Office of the European Union.  
https://www.drugsandalcohol.ie/31119/









   











1 Registries for quality 
in prevention – 
Xchange and Healthy 
Nightlife Toolbox
As previously outlined in Drugnet Ireland, the 
Best Practice Portal of the European Monitoring 
Centre for Drugs and Drug Addiction (EMCDDA) 
is designed to help practitioners find practical 
and reliable information on what works (and what 
does not) in the areas of prevention, treatment, 
harm reduction, and social reintegration.1 It 
aims to support these stakeholders to identify 
tried and tested interventions quickly, allocate 
resources to what is effective, and improve 
interventions applying tools, standards, and 
guidelines. As part of the portal, the EMCDDA 
hosts and maintains the Xchange prevention 
registry2 and the Healthy Nightlife Toolbox 
(HNT).3 Stakeholders can use these registries to 
make evidence-based decisions about effective 
interventions.
Context
As discussed in the article on the Civil Society 
Forum on Drugs (CSFD) on page 27 in this 
publication, the Council conclusions on the 
implementation of the EU Action Plan on Drugs 
2013–2016 regarding minimum quality standards 
in drug demand reduction in the European 
Union4 were adopted in 2015 by the Council of 
the European Union (EU). Among the standards 
adopted was that professionals have access to 
knowledge on effective drug demand reduction 
interventions. While there is a growing evidence 
base of what works, this often is not reflected in 
the interventions funded and delivered across 
Europe. The EMCDDA notes that ‘access to 
evidence-based prevention programmes is still 
limited and they remain under-utilised compared 
to prevention strategies with no empirical 
evidence for effectiveness’.5 The Xchange 
registry and the HNT aim to address  
this problem.
Xchange prevention registry
Xchange is an online registry of evidence-based 
prevention interventions that aims to provide 
stakeholders with access to the evidence 
needed to make better decisions about which 
interventions to fund and implement. It includes:
• Manualised interventions for which European 
evaluation studies have shown beneficial 
outcomes relating to substance use as well as 
programmes for youth offending and bullying.
• Environmental prevention interventions, 
which are strategies that target the contexts 
for behaviour by changing the prompts and 
cues that guide behaviour. The purpose 
of environmental prevention policies and 
interventions is to limit the availability of 
unhealthy or risky behaviour opportunities 
or to promote the availability of healthy 
opportunities.
For each intervention on the registry there is:
• Information on the effectiveness of the 
programme/intervention from their 
evaluation(s)
• Information on the experiences of 
professionals who have implemented the 
programmes/interventions in Europe. The 
aim of this second strand is to help decision-
makers assess the ease with which the 
approach could be implemented in different 
social, cultural, and organisational contexts.
Examples of Irish-delivered manualised 
programmes registered on Xchange and rated as 
‘likely to be beneficial’ are: Good Behaviour Game; 
Functional Family Therapy; and Olweus Bullying 
Prevention Programme.
Healthy Nightlife Toolbox
Much like Xchange, the Healthy Nightlife Toolbox 
(HNT) provides evidence to support local, regional, 
and national policymakers and prevention 
workers in their decision-making about which 
interventions to select to help reduce harm 
among young people from alcohol and drug use in 
nightlife settings. At its core are three databases: 
evaluated interventions, literature on these 
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interventions, and other literature within the field 
of nightlife alcohol and drug prevention. No Irish 
projects have been logged on the database to 
date. Interventions covered include pill testing, 
training for staff and professionals, legislative 
measures, and education for nightlife users.
Getting your intervention included
If you are a stakeholder who thinks an 
intervention you are involved with should be 
included on either of these registries, you can 
access more information on doing so.
• Xchange: Stakeholders are invited to 
carry out a self-assessment to see if their 
intervention qualifies for inclusion at: 
https://www.emcdda.europa.eu/best-
practice/xchange
If they do not qualify, they can access an 
implementation toolbox which combines 
didactical elements with training tools 
and guidelines to help them make their 
interventions ready for inclusion in Xchange 
and fitter for real-life use: 
https://www.emcdda.europa.eu/best-
practice/xchange/implementation-toolbox
Prevention registries   continued • HNT: Stakeholders are invited to contribute  
to the registry at: 
http://www.hntinfo.eu/contribute 
Alternatively, stakeholders can send an email 
to: HNT@emcdda.europa.eu
Lucy Dillon
1 Dillon L (2021) EMCDDA Best Practice Portal. 
Drugnet Ireland, 76 (Winter): 13–14.  
https://www.drugsandalcohol.ie/33960/




3 Further information on HNT is available online at:  
http://www.hntinfo.eu/
4 Council of the European Union (2015) Council 
conclusions on the implementation of the EU 
Action Plan on Drugs 2013–2016 regarding minimum 
quality standards in drug demand reduction in the 
European Union. 11985/15. Brussels: Council of the 
European Union.  
https://www.drugsandalcohol.ie/24317/
5 European Monitoring Centre for Drugs and Drug 
Addiction (EMCDDA) (2021) About the Xchange 
prevention registry. Lisbon: EMCDDA. Available 
online at:  
https://www.emcdda.europa.eu/best-practice/
xchange/about
Tabor Group annual 
report, 2019
The Tabor Group is a provider of residential 
addiction treatment services in Ireland. It aims 
to offer hope, healing, and recovery to clients 
suffering from addictions through integrated and 
caring services. In addition to three residential 
facilities, the organisation provides a continuing 
care programme to clients who have completed 
treatment in order to assist with their recovery. 
It also offers counselling to families whose loved 
ones are struggling with an addiction. In 2020, 
the Tabor Group published its annual report.1 
This article highlights services provided by the 
Tabor Group to individuals with a substance use 
addiction in 2019.
Tabor Lodge: residential addiction 
treatment centre
Tabor Lodge is a residential addiction treatment 
centre for the treatment of people addicted to 
alcohol, drugs, gambling, and food. It is situated 
15 miles south of Cork city. Tabor Lodge is guided 
by the Minnesota Model of addiction treatment 
in delivering its treatment programme. This 
model is characterised by the understanding 
that addiction is primarily a substance use 









   


















Hypnotics and sedatives 3 2
Other substances 2 1
Table 1: Specific drug of choice for clients admitted to Tabor Lodge: residential addiction 
treatment centre, in 2019
Tabor Group report, 2019   
continued
programme is to educate clients on the dynamics 
of this disorder as they manifest in the life of 
the individual. Another important focus of the 
treatment programme is to assist clients develop 
the skills necessary to manage their disorder 
while going forward in their lives.
A total of 185 clients (74% male) were admitted 
to Tabor Lodge for residential treatment of 
addiction in 2019, of whom 178 completed 
treatment. A breakdown of the specific drug 
of choice for admissions in 2019 is shown in 
Table 1. The report noted a 19% increase in 
clients reporting cocaine as their drug of choice 
compared with 2018.
Source: Tabor Group (2020)











Table 2: Specific drug of choice for clients admitted to Tabor Fellowship: men’s residence 
extended treatment centre, in 2019
Source: Tabor Group (2020)
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Table 3: Specific drug of choice for clients admitted to Tabor Renewal: women’s residence 
extended treatment centre, in 2019
Source: Tabor Group (2020)
Tabor Group report, 2019   
continued
Tabor Fellowship: men’s residence 
extended treatment centre
The extended treatment programme for men 
is based on the Hazelden Minnesota Model 
and promotes ‘total abstinence’. The aim is to 
build on and consolidate the work of recovery 
already begun in primary treatment – even if that 
treatment was not in the recent past and the 
client is struggling to maintain sobriety.
In 2019, some 68 clients were admitted to Tabor 
Fellowship for extended treatment; a total of 
43 individuals completed the programme. A 
breakdown of the specific drug of choice for 
admissions to Tabor Fellowship in 2019 is shown 
in Table 2. The report observed that 94% of 
clients reported cocaine as their specific choice 
of drug.
Tabor Renewal: women’s residence 
extended treatment centre
Tabor Renewal works with women who have 
already completed a primary 28-day treatment 
programme. It is a 12-week residential extended 
treatment programme, where clients learn 
to find routine, balance, and structure. Tabor 
Renewal is the only Minnesota Model extended 
treatment centre for women based in Ireland 
and was opened in 1999.
In 2019, some 42 clients were admitted to Tabor 
Renewal, of which 31 completed the programme. 
Sixty-two per cent of these clients were aged 
between 18 and 34 years. A breakdown of the 
specific drug of choice for admissions to Tabor 
Renewal in 2019 is shown in Table 3. That year, 
93% of clients admitted presented with a history 
of alcohol abuse.
Seán Millar
1 Tabor Group (2020) Tabor Group annual report 










   
















AcoRN, the UK-Ireland Alcohol Research 
Network, was formally launched on Thursday, 29 
April 2021.1 The aim of AcoRN is to generate and 
build capacity for interdisciplinary research into 
the development, adoption, implementation, and 
evaluation of alcohol policy innovation in Ireland 
and the United Kingdom (UK).
Why the need for this initiative?
Alcohol has become an increasingly important 
public health issue for both the Irish and 
UK governments. In Ireland, the Public 
Health (Alcohol) Act 2018 was a milestone in 
Government recognition that alcohol and its 
associated harms should be considered from 
a population health perspective. The passing 
of the Act demonstrated that while consuming 
alcohol is popular among Irish people and 
contributes to the Irish economy, it is also the 
cause of many social, criminal, and, of course, 
healthcare costs. Government policies were 
therefore needed to address this. But how do 
we quantify the intended and unintended effects 
of policies, not just on health, but on social, 
economic, and cultural aspects?
By combining the knowledge of alcohol policy 
researchers from a wide range of backgrounds 
interested in the study of alcohol policy, AcoRN 
aims to develop partnerships, promote the 
sharing of research ideas and methodologies, 
and identify common research priorities to 
deliver on the alcohol policy research needed in 
the UK and Ireland in the coming years.
Themes of AcoRN
The activities of AcoRN are organised around 
four themes:
• Price – making alcohol less affordable through 
price policies
• Availability – making alcohol less easily 
available
• Marketing – by reducing how much alcohol is 
advertised and promoted
• Politics – policymaking research.
AcoRN personnel
The initiative is the brainchild of Professor 
Joe Barry and Professor Niamh Fitzgerald and 
has been funded by the Economic and Social 
Research Council (UK) and the Irish Research 
Council. Professor Barry, a specialist in public 
health medicine in Trinity College Dublin, has 
worked in substance use for 30 years, while 
Professor Fitzgerald at the University of Stirling 
specialises in studies drawing on expertise 
across different academic disciplines to 
better understand intended and unintended 
consequences of policy interventions. They are 
joined in founding AcoRN by 14 co-applicants 
from 13 institutions across the UK and Ireland.
Launch of AcoRN
Suzanne Costello, CEO of the Public Health 
Institute of Ireland, commenced the online 
launch of AcoRN, which was attended 
by more than 60 researchers, policy and 
community colleagues, and other stakeholders. 
Professor Joe Barry delivered the first plenary 
presentation outlining the background and 
structure of the network. Attendees then chose 
two of the four breakout sessions based on the 
AcoRN themes.
Theme 1: Alcohol pricing
Colin Angus of the University of Sheffield led 
the first theme discussing alcohol pricing policy. 
Those attending had the opportunity to share 
their opinions, knowledge, and experiences 
in smaller groups. Minimum unit pricing (MUP) 
dominated the discussion, with Irish attendees 
raising their concerns of commencing MUP 
without it simultaneously commencing in 
Northern Ireland and the potential ramifications 
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on the border areas in Ireland. Those from the 
UK spoke of the success of MUP in Scotland 
despite England not commencing at the same 
time.
Theme 2: Alcohol availability
Alcohol availability discussions were led by 
Professor Niamh Shortt of the University of 
Edinburgh. She outlined fascinating research 
investigating the impact of the high-density 
presence of alcohol premises and how exposure 
to branding and advertising shapes our 
behaviour. The group discussed how using small 
area data and consumption data can increase 
our knowledge of alcohol availability.
Theme 3: Alcohol marketing
The theme of alcohol marketing was led by Dr 
Pat Kenny of Technological University Dublin. 
Discussion focused on the Public Health (Alcohol) 
Act 2018 and how, as the components have been 
commenced in phases, the effect of each can be 
evaluated individually.
Theme 4: Alcohol politics
The final theme of alcohol politics/policymaking 
was led by Dr Matt Lesch of the University of 
York. Attendees discussed the conflict of interest 
when industry plays a role in policymaking 
and how we can better understand the role 
of ‘industry actors’ who focus on personal 
responsibility when it comes to alcohol 
consumption. Also discussed were how drinking 
at home has become the new norm and how 
work is being done on alcohol and homelessness.
Conclusion
In the final session, Professor Fitzgerald 
presented the next steps for AcoRN: a website, 
blog, and social media account;2 a series of 
seminars to build teams for future research; early 
career researchers to be given opportunities 
to work with more experienced colleagues; a 
workshop to build capacity on alcohol policy 
research and allowing time for teams to develop 
funding applications; and a UK/Ireland open 
research symposium.
Professor Fitzgerald concluded the launch 
by outlining the aspirations and next steps of 
AcoRN:
By developing new partnerships between 
areas of research and different countries, 
sharing ideas and identifying common 
priorities, we will be able to effectively grow 
and diversify the strength of the vital research 
in this area.
Anne Doyle
1 Further information about the AcoRN initiative is 
available on their website:  
http://alcoholresearch-uk-irl.net/ 
2 To follow the activities of AcoRN on social media, 
their twitter handle is @AcornAlcohol.
Launch of AcoRN   continued
The National Family 
Support Network 
The National Family Support Network (NFSN)1 
ceased operations on Monday, 26 April 2021. 
The original Family Support Network was 
established in 2000 following the successful 
organisation by family support groups of the 
first Service of Commemoration and Hope. This 
spiritual, multidenominational service is held in 
remembrance of loved ones lost to substance 
misuse and related causes and to publicly 
support and offer hope to families living with 
the devastation that substance misuse causes. 
Subsequent to the success of this event and the 
evident desire of families to continue with such 
events, the Family Support Network was formed 
under the auspices of the CityWide Drugs Crisis 
Campaign.
The Family Support Network membership 
consists of representatives of family support 
groups, individual family members, and those 









   












use drugs across the island of Ireland. The 
network was set up as an autonomous self-help 
organisation that provided support to families 
and respected the experiences of families 
affected by substance misuse in a welcoming 
non-judgemental atmosphere. In 2007, the 
Family Support Network gained recognition as an 
autonomous national organisation. 
On Monday, 22 March 2021, the NFSN held its 
22nd Annual Service of Commemoration and 
Hope in the Church of Our Lady of Lourdes, 
Sean MacDermott Street, Dublin, with this 
yearʼs service available online.2 Speaking at the 
service, the networkʼs outgoing CEO Sadie Grace 
highlighted the ongoing devastation associated 
with drug use, including drug-related deaths, 
for families and communities across Ireland. 
She called for person-centred care, access to 
treatment, and early interventions for people 
who use drugs. Sadie emphasised that living 
with a family member who has an addiction to a 
substance(s) was a major life stressor, with other 
family members experiencing both physical 
and emotional health impacts as a result. She 
stressed that these families represent the hidden 
costs of the drug crisis in Ireland. She also called 
on the State to take meaningful action to combat 
the ‘horror’ of drug-related intimidation.
Achievements of NFSN
As Sadie retires from her role in NFSN after giving 
27 years to family support, she outlined some 
of the achievements of the network during her 
leadership:
• Advocating and securing the development 
of the National Drug-Related Deaths Index 
(NDRDI)
• Advocating and assisting in achieving greater 
access to naloxone, including involvement in 
the HSE Naloxone Demonstration Project
• Assisting families pay for funeral expenses, 
with the generous support of the Archdiocese 
of Dublin
• Advocating and achieving advanced 
bereavement-specific supports and respite 
for families affected by drug-related deaths
• Developing interventions to help families 
experiencing drug-related intimidation 
• Developing and operating a biannual 
bereavement support programme
• Reporting on the impact of drug-related 
deaths on families, which led to the first 
specific addiction bereavement support for 
families
• Conducting research into the outcomes, 
especially health outcomes for family 
members living with loved ones with 
addiction.
She said the network continued to call for:
• Family support coordinators to be based 
in every drug taskforce area; and she was 
encouraged by the support of Minister  
Frank Feighan TD in this regard
• Actions to be prioritised in the national drugs 
strategy for families, including supports for 
kinship carers and respite for families
• Specific national bereavement support 
services for families
• Meaningful action on the issue of drug-related 
intimidation.
Recognition of NFSN
In his address, Minister Feighan reinforced the 
message that drug addiction is a health issue 
and not a criminal issue, where focus must be 
on recovery options not punishment. Drug-
related intimidation is an area of concern, 
which he believes requires special attention, 
and he welcomed the evaluation of the drug-
related intimidation reporting programme 
carried out by the NFSN and An Garda Síochána. 
Minister Feighan supports the Government’s 
decision to develop a medically supervised 
drug injecting facility in Dublin and highlighted 
that, as a society, Ireland needs to have a 
more open and tolerant approach to drug use. 
An Taoiseach Micheál Martin, in his address, 
gave a commitment to fulfil the Government's 
responsibility in the national drugs strategy.
National Family Support Network    
continued
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Many speakers on the night of the Service of 
Commemoration and Hope praised the work 
of NFSN and its dedicated staff, especially the 
unreserved dedication, commitment, and drive 
of Sadie Grace in her support to people and 
family members affected by drug use. They 
passed on their best wishes to Sadie while she 
moves to a new chapter in her life.
Following the service, panel discussions were 
held to discuss various aspects in relation to 
NFSN, the service itself, and the impact of drug 
use on families, which can be viewed online via 
the NFSN website.2 Contact details for local and 
regional family support networks are currently 
available via the NFSN website.1
Ena Lynn
1 The National Family Support Network ceased 
operations on Monday, 26 April 2021, as reported on 
their website: www.fsn.ie 
2 To view the service, visit:  
http://www.fsn.ie/news-events/events/service-of-
commemoration-and-hope-22nd-march-2021
National Family Support Network    
continued
HRB National Drugs 
Library survey, 2021
The HRB National Drugs Library,1 based within 
the Health Research Board, supports those 
working to develop the knowledge base around 
drug, alcohol, and tobacco use in Ireland. In 
February 2021, staff of the library asked visitors 
to its website to fill in a short survey about their 
experience of the website and library services. 
Forty-two responses were received and some of 
the survey findings are presented here. 
Survey findings
In terms of what the respondents liked about 
the website, most considered it easy or simple 
to use, up-to-date, and user friendly. They liked 
that they could access this large collection in 
one place.
It is a fantastic and well curated resource  
and picks up relevant research across the 
country. It’s brilliant.
User-friendly, easy to find what I need.
In terms of what they thought could be improved 
upon, the search facility was the number 
one issue mentioned. Navigating the site was 
also a problem for some respondents. A few 
respondents mentioned that they would like to 
see more data, especially Irish data.
Sometimes [it’s] hard to pin down what I  
want to find.
Can be hard to find [an] exact match in 
search sometimes.
To assess the impact of the library on the work 
of those working in the area of substance use, we 
asked respondents if the library had contributed 
to, or changed, their work or study. Figure 1 
shows how the library has enabled evidence-
informed policy, practice, research or education 
among the 42 respondents.
Discussion
The wealth of information in responses is 
certainly guiding our developments. We know, for 
example, that finding good-quality research and 
relevant information can be difficult, especially as 
our collection grows. We are working on honing 
and improving our subjects (keywords) and 
search so that users can more easily refine their 
criteria. We hope that the recent addition of the 
advanced search options – ‘review’, ‘guideline’, 
‘peer reviewed articles’, ‘Irish-related’ and 









   












Figure 1: How the drugs library enabled evidence-informed policy, practice, research or education
The HRB National Drugs Library has...
supported me to work in an evidence-based way
provided evidence that I would not have otherwise...
informed a policy, project or programme
meant I was better informed about interventions
contributed signicantly to my continuing...
informed or changed an aspect of my practice on the...
contibuted signicantly to course assignments
contibuted signicantly to developing course content
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National Drugs Library survey    
continued
The key Irish data page is designed to draw 
together published data on the situation in 
Ireland. It includes pages for Irish prevalence, 
treatment, and deaths data. As we identify other 
data sources, we will add them to this resource. 
We would like to thank all our respondents 
for their time, useful suggestions, and kind 
comments. Further feedback can be emailed to 
drugslibrary@hrb.ie
Mary Dunne
1 The HRB National Drugs Library website can be 
accessed at https://www.drugsandalcohol.ie/ 
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Civil society involvement in harm reduction drug 
policy: reflections on the past, expectations for 
the future
OʼGorman A and Schatz E (2021) Harm Reduction 
Journal, 18: 17. 
https://www.drugsandalcohol.ie/33975/  
This paper is based on the presentations and 
discussions from a workshop on ʼCivil Society 
Involvement in Drug Policyʼ hosted by the 
Correlation – European Harm Reduction Network 
at the International Society for the Study of Drugs 
Policy (ISSDP) annual conference in Paris, 2019. 
In the aftermath of the workshop, the authors 
analysed the papers and discussions and identified 
the key themes arising to inform CSI [civil society 
involvement] in developing future harm reduction 
policy and practice.
Civil society spaces are colonised by a broad 
range of civil society actors lobbying from different 
ideological standpoints including those advocating 
for a ’drug free world’ and those advocating for 
harm reduction. In these competitive arena, it 
may be difficult for harm reduction orientated 
CSOs [civil society organisations] to influence the 
policy process. However, the current Covid-19 
public health crisis clearly demonstrates the 
benefits of partnership between CSOs and political 
institutions to address the harm reduction needs 
of people who use drugs. The lessons drawn from 




How a moral panic influenced the world’s first 
blanket ban on new psychoactive substances
Windle J and Murphy P (2021) Drugs: Education 
Prevention and Policy, Early online. 
https://www.drugsandalcohol.ie/34014/ 
This review found that head shops were largely 
tolerated when they sold cannabis paraphernalia 
(2000–2008), possibly indicating the normalisation 
of cannabis in Ireland. Some mild condemnatory 
language emerges between 2008 and 2009 when 
head shops began selling some new psychoactive 
substances [NPS]. The review suggests that 
the 2010 Act was partly a product of a moral 
panic, driven and managed by a range of moral 
entrepreneurs and involving both peaceful and 
violent protests. Unlike some traditional moral 
panics, young people were not identified as folk 
devils but rather as under threat from a new drug 










   












PREVALENCE AND CURRENT SITUATION
ADHD stimulant medication misuse and 
considerations for current prescribing practice: 
a literature review
Carolan D (2021) Irish Journal of Medical Science, 
Early online. 
https://www.drugsandalcohol.ie/33754/ 
This study aimed to chronicle the development of 
medical and scientific opinion on the subject of 
substance use disorders (SUD) outcomes in ADHD 
[attention deficit hyperactivity disorder] and to 
appraise most recently published research in this 
sphere. 
Consideration of the impact that variable 
treatment trajectories may have on the risk of later 
SUD development is recommended, with further 
research potentially leading to the development 
of different management pathways based on an 
individual's multivariate treatment profile.
College students’ perspectives on an alcohol 
prevention programme and student drinking  
– a focus group study
Calnan S and Davoren MP (2021) Nordic Studies on 
Alcohol and Drugs, Early online 
https://www.drugsandalcohol.ie/34130/   
This qualitative study aimed to address this gap 
[in research] by examining college students’ 
perspectives in the context of an alcohol 
prevention programme for college students in 
Ireland.
Viewing the findings through a social-ecological 
lens, students seemed to collectively acknowledge 
the different layers of influence on student 
drinking, acknowledging the complex nature of this 
issue. Providing a greater variety of leisure spaces, 
including alcohol-free environments, was viewed 
particularly favourably by the student participants 
in terms of solutions proposed.
Recent publications   continued Trends in strong opioid prescribing in Ireland: a 
repeated cross-sectional analysis of a national 
pharmacy claims database between 2010 and 
2019
Norris BA, Smith A, Doran S and Barry M (2021) 
Pharmacoepidemiology and Drug Safety,  
30: 1003–1011.  
https://www.drugsandalcohol.ie/34072/  
This study investigated strong opioid prescribing in 
Irish General Medical Services (GMS) patients over 
a 10-year period.
This study found an overall increase in strong 
opioid prescribing in Ireland between 2010 and 
2019, particularly in older adults. Tramadol was 
the most frequently prescribed product, with 
oxycodone and tapentadol prescribing increasing 
markedly over the study period.
Potential alcohol use disorder among MSM 
in Ireland - findings from the European MSM 
internet survey (EMIS 2017)
Daly FP, OʼDonnell K, Davoren MP, Noone C, 
Weatherburn P, Quinlan M, Foley B, Igoe D and 
Barrett PM (2021) Drug and Alcohol Dependence, 
223: 108698 
https://www.drugsandalcohol.ie/34090/  
Alcohol consumption is a major public health 
concern in Ireland. Alcohol use disorder (AUD) 
disproportionately affects men who have sex 
with men (MSM). However, little is known about 
the prevalence of AUD in this group in Ireland 
specifically, and the characteristics of MSM who 
may struggle with this.
The prevalence of AUD appears to be higher in the 
MSM population compared to the general male 
population in Ireland. Targeted interventions may 
be warranted to reduce the burden of AUD among 
MSM.
43
Issue 78  |  Sum
m
er 2021     drugnet Ireland      
Improvement in psychological wellbeing among 
adolescents with a substance use disorder 
attending an outpatient treatment programme
Gamage NM, Darker CD and Smyth BP (2021) Irish 
Journal of Psychological Medicine, Early online. 
https://www.drugsandalcohol.ie/34026/ 
This study aimed to examine the impact of an 
outpatient substance use treatment programme 
upon the psychological wellbeing of adolescents.
The findings indicate that substance use treatment 
for adolescents is associated with important 
psychological and behavioural improvements.
Factors associated with changes in consumption 
among smokers and alcohol drinkers during the 
COVID-19 ʼlockdownʼ period
Reynolds CME, Purdy J, Rodriguez L and McAvoy 
H (2021) European Journal of Public Health, Early 
online. 
https://www.drugsandalcohol.ie/34071/ 
This study aimed to identify factors associated 
with changes in alcohol and tobacco consumption 
during the strictest period of public health social 
measures (PHSM) ʼlockdownʼ.
A mixed picture was evident in terms of changes in 
consumption among current smokers and drinkers. 
Increased consumption was more commonly 
reported than reductions. Increased consumption 
was associated with psychological distress and 
socio-economic factors. Policies and services 
should consider a response to widening inequalities 
in harmful consumption.
Recent publications   continued Doctor–patient interactions that exclude patients 
experiencing homelessness from health services: 
an ethnographic exploration
OʼCarroll A and Wainwright D (2021) BJGP Open,  
5(3): 0031. 
https://www.drugsandalcohol.ie/34052/
This research sought to explore barriers to health 
service usage for people experiencing homelessness.
There are certain recurrent interactions between 
people experiencing homelessness and doctors 
that result in the exclusion of people experiencing 
homelessness from health services.
How punitive are the public? Attitudes towards 
crime and punishment in Ireland
Rice O (2021) The Dublin University Journal of 
Criminology, 1: 53-76. 
https://www.drugsandalcohol.ie/34056/ 
This article explores the nature of public attitudes 
towards the use of imprisonment in Ireland in 2019 
through the use of a quantitative survey.
The survey demonstrates that knowledge of the 
prison system and education level are positively 
correlated with rehabilitative attitudes towards crime 
and punishment, and in light of these findings, the 
article recommends a public information campaign 
to combat punitive rhetoric surrounding crime and 
punishment.
The healthy addiction treatment recovery model: 
developing a client-driven, nurse-led addiction 
nursing model
Comiskey C, Galligan K, Flanagan J, Deegan J, 
Farnann J and Hall A (2021) Journal of Addictions 
Nursing, 32(1): e11-e20. 
https://www.drugsandalcohol.ie/33854/ 
The aim of this study was to address this gap [in 
research] within addiction nursing and to develop an 
evidence-based addiction nursing model.
Results informed the development of the Healthy 
Addiction Treatment Recovery Model. The model 










   












The reasons for the emergence of a drug market in 
rural Ireland in the period from 2009-2019. A case 
study of a small town in West Cork
White D (2021) The Dublin University Journal of 
Criminology 1: 77-95. 
https://www.drugsandalcohol.ie/34055/ 
Cannabis has historically been Ireland’s most 
consumed illicit drug. Recent years, however, have 
witnessed a significant rise in cocaine consumption, 
with Gardaí and drug counsellors recently reporting 
the drug’s availability in every village, town and city 
in Ireland, as well as rural areas. The research site 
for this study is no different: interviews and media 
reports note the increasing availability of different 
drugs, including illegally obtained prescription drugs 
and MDMA, but especially cocaine.
The literature on Irish drug markets is slim, and 
almost non-existent for rural drug markets. As such, 
this article seeks to fill a gap in the literature by 
investigating the development of a rural Irish drug 
market in Ireland, its history and the form it currently 
takes. Within this discussion the article will critically 
explore the existence of county line-type operations 
in Ireland and migration patterns of Irish drug dealers. 
Examining the alcohol-related consequences of 
adult drinkers who self-report medicating low 
mood with alcohol: an analysis of the 2001-2002 
National Epidemiologic Survey on Alcohol and 
Related Conditions survey data
McHugh R and McBride O (2021) Alcohol, 94: 9–15. 
https://www.drugsandalcohol.ie/34032/ 
The aim of this paper is to examine the alcohol-
related consequences experienced by adults who 
experienced a two-week period of low mood and 
identify as a ʼself-medicatorʼ compared to those who 
do not.
It was revealed that the hazardous drinking group who 
self-medicated experienced more consequences 
even at low levels of severity. As the self-medicating 
hazardous drinking group also showed the highest 
estimates for alcohol use disorder severity, this may 
indicate that this group are high functioning self-
medicators who are trying to regulate their drinking, 
and may not be as clinically high risk as expected, due 
to their drinking patterns.
Recent publications   continued New psychoactives within polydrug use 
trajectories – evidence from a mixed-method 
longitudinal study
Higgins K, OʼNeill N, OʼHara L, Jordan J-A, McCann 
M, OʼNeill T, Clarke M, OʼNeill T, Kelly G and 
Campbell A (2021) Addiction, 116(9): 2454–2462. 
https://www.drugsandalcohol.ie/33716/ 
This study aimed to provide public health-
related research evidence on types and usage 
patterns of new psychoactive substances (NPS), 
developmental pathways into NPS and decision-
making factors for, and associated harms of, NPS 
use.
In Northern Ireland, new psychoactive substances 
appear to be a feature of broader polydrug use 
rather than a standalone class of drug use.
A qualitative study of the perceptions of mental 
health among the Traveller community in Ireland
Villani J and Barry MM (2021) Health Promotion 
International, Early online. 
https://www.drugsandalcohol.ie/33798/  
This study explores Travellersʼ perceptions 
of mental health and its determinants. It also 
identifies the most relevant factors for promoting 
positive mental health and wellbeing among this 
socially excluded group. 
The findings suggest that Travellersʼ mental 
health is multidimensional and requires a socio-
ecological approach that addresses the wider 
determinants of health. Community mental health 
promotion initiatives should focus on reducing 
discrimination, enhancing social and emotional 
wellbeing and self-esteem, improvement of living 
conditions, reduced mental health stigma, and the 
promotion of Traveller culture and positive self-
identity.
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E-cigarette-only and dual use among 
adolescents in Ireland: emerging behaviours  
with different risk profiles
Bowe AK, Doyle F, Stanistreet D, OʼConnell E, 
Durcan M, Major E, OʼDonovan D and Kavanagh 
P (2021) International Journal of Environmental 
Research and Public Health, 18(1): 332. 
https://www.drugsandalcohol.ie/33740/ 
The study is a cross-sectional analysis of the 2018 
Planet Youth survey completed by 15-16 year olds 
in the West of Ireland in 2018. The outcome of 
interest was current nicotine product use, defined 
as use at least once in the past 30 days.
This is the first study to show, among a 
generalisable sample, that dual-use is the most 
prevalent behaviour among adolescent nicotine 
product users in Ireland. Risk factor profiles differ 
across categories of use and prevention initiatives 
must be cognisant of this.
Recent publications   continued Correlates of patterns of cannabis use, abuse 
and dependence: evidence from two national 
surveys in Ireland
Millar SR, Mongan D, OʼDwyer C, Long J, Smyth BP, 
Perry IJ and Galvin B (2021) European Journal of 
Public Health, 31(2): 441–447.  
https://www.drugsandalcohol.ie/33859/ 
This study determined factors associated with 
recent and current cannabis use. In addition, we 
explored factors related to having a cannabis use 
disorder (CUD) – defined using the Diagnostic and 
Statistical Manual of Psychiatric Disorders – among 
current users.
Males, adolescents/young adults and individuals 
with lower educational levels are more likely to be 
current users of cannabis and are at a greater risk 
of having a CUD. Health professionals should be 
aware of these factors to improve detection and 
prevention of CUD.
ʼI’m always hiding and ducking and divingʼ: the 
stigma of growing older on methadone
Mayock P and Butler S (2021) Drugs: Education 
Prevention and Policy, Early online. 
https://www.drugsandalcohol.ie/33894/ 
Conducted in Ireland and drawing on data from 
a qualitative study of 25 long-term clients of 
methadone treatment, this paper examines the 
stigma narratives of patients who are growing older 
as MMT [methadone maintenance treatment] 
patients.
The findings presented reflect the marginal position 
of addiction treatment within the wider healthcare 
system in Ireland and a failure to normalize 
methadone treatment.
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